Edelman has recruited Pfizer UK’s corporate affairs director Emma Lynn as global health deputy.
Lynn, who did a 16-year run at Pfizer, reports to Kirsty Graham, head of the specialized global health offering.
She also put in stints at GSK and Burson-Marsteller.
Edelman Health chalked up a robust performance during the 2020 pandemic year as fee income rose 9.1 percent to $168.8M. The firm is No. 2 behind Real Chemistry, the former W2O Group, on O’Dwyer’s roster of healthcare firms.
Edelman also added Lynda Gordon as executive VP, global DXI Health lead.
Gordon joins from the VP-analytics post at Merkle and reports to Yannis Kotziagkiaouridis, global chief data and analytics officer.